Ben’s Editorial

jun
2013
Dear Industry Colleagues,

We hope that 2013 is continuing to be a good year for all of our clients, vendors, and employees. QPS is pleased to take this opportunity to inform you about our continued growth and expansion during the second quarter of 2013.

feb
2013
Dear Industry Colleagues,

I hope you’ve all had a great start to 2013. On behalf of QPS’ management team, we would like to express our sincere appreciation to all of our clients, vendors, and employees for making 2012 successful for QPS. We are sincerely thankful for the opportunity to work with our clients and vendors, and recognize the contribution and hard work from our employees to make 2012’s success possible.

nov
2012
Dear Industry Colleagues,

We hope you all had great Thanksgiving Holidays.  On behalf of QPS management team, we would like to express our sincere appreciation to all of our clients, vendors and employees.  We appreciate the opportunity to work with our clients and appreciate all the hard work from our employees all year long.

 

aug
2012
Dear Industry Colleagues,

It is my privilege to update you on QPS’ continuous growth and global expansion. At QPS, we appreciate opportunities to work with our clients and interact with industry colleagues in the scientific community. We know we all have a common goal: to help develop medicines that will benefit patients worldwide.

may
2012
Dear Industry Colleagues,

These are exciting, dynamic times for QPS. After experiencing a challenging time in our industry in 2009-2010, QPS decided to compete aggressively to earn 'preferred provider status' from more clients. We made four acquisitions in 2010/2011 so that we can now offer our clients an impressive global capability in bioanalysis, translational medicine, preclinical, early clinical, and phase 2 - 4 clinical services.

top
20 years in pharma R&D navigation